Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 15 EU countries
White Paper: Evidence Requirements for Interventional Procedures Program at NICE in the United Kingdom
Get insights from MTRC White Papers to advance your understanding of European market access for medical procedures
Recent news and posts
First device obtained regular reimbursement after the pre-LPPR scheme in France
On December 19, 2025, the Order registering the Symplicity Spyral renal denervation catheter in the List of Reimbursable Products and Services (LPPR) was released. A new section 7 "Radiofrequency renal denervation devices" was added under LPPR Title V, Chapter 2, and the code 5262450 "Renal denervation catheter, MEDTRONIC, SYMPLICITY SPYRAL" with a tariff of €4,789.20 was created.
Obtaining regular LPPR reimbursement for the Symplicity Spyral renal denervation catheter marks the first successful transition of a medical device after the French innovative payment scheme, known as the transitional coverage of medical devices (prise en charge transitoire, PECT), or the "pre-LPPR" scheme. The device has been covered under the pre-LPPR scheme since December 2022.
This registration followed a positive opinion on the regular LPPR registration of the Symplicity Spyral issued by the National Committee for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December 2023. The device received sufficient Actual Benefit (SA) and level III (moderate improvement) of Added Clinical Value (ASA) compared to the absence of a therapeutic alternative.
A positive CNEDiMTS's opinion on the device was accompanied by a positive opinion on the registration of the associated procedure ("Renal denervation by radiofrequency by transcutaneous vascular route") in the CCAM Classification (i.e., a joint evaluation of a medical device and an associated medical procedure was performed). The corresponding CCAM code AJNF129 was implemented in the CCAM Classification by the Decision of the National Association of Health Insurance Funds (UNCAM) of December 4, 2025.
See the details in French here, here, here, here, and here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.